Table 4.

Annual prevalence (per 1000 persons) of MASH in Korea.

Year	Total			Male			Female
	No. of Cases	Population	Incidence (95% CI)	No. of Cases	Population	Incidence (95% CI)	No. of Cases	Population	Incidence (95% CI)
2010	24,496	49,879,812	0.49 (0.48–0.50)	12,863	24,977,164	0.51 (0.51–0.52)	11,633	24,902,648	0.47 (0.46–0.48)
2011	43,005	50,111,476	0.86 (0.85–0.87)	23,311	25,081,788	0.93 (0.92–0.94)	19,694	25,029,688	0.79 (0.78–0.80)
2012	55,921	50,345,325	1.11 (1.10–1.12)	30,541	25,187,494	1.21 (1.20–1.23)	25,380	25,157,831	1.01 (1.00–1.02)
2013	66,771	50,558,952	1.32 (1.31–1.33)	36,142	25,282,928	1.43 (1.41–1.44)	30,629	25,276,024	1.21 (1.20–1.23)
2014	73,447	50,763,158	1.45 (1.44–1.46)	39,679	25,374,486	1.56 (1.55–1.58)	33,768	25,388,672	1.33 (1.32–1.34)
2015	91,245	50,951,719	1.79 (1.78–1.80)	49,069	25,458,058	1.93 (1.91–1.94)	42,176	25,493,662	1.65 (1.64–1.67)
2016	115,232	51,112,972	2.25 (2.24–2.27)	61,654	25,527,815	2.42 (2.40–2.43)	53,578	25,585,157	2.09 (2.08–2.11)
2017	185,656	51,230,704	3.62 (3.61–3.64)	102,666	25,576,752	4.01 (3.99–4.04)	82,990	25,653,952	3.23 (3.21–3.26)
2018	316,035	51,300,880	6.16 (6.14–6.18)	173,851	25,601,961	6.79 (6.76–6.82)	142,184	25,698,919	5.53 (5.50–5.56)
2019	384,098	51,337,424	7.48 (7.46–7.51)	211,430	25,609,342	8.26 (8.22–8.29)	172,668	25,728,082	6.71 (6.68–6.74)
2020	432,276	51,349,259	8.42 (8.39–8.44)	237,555	25,606,081	9.28 (9.24–9.31)	194,721	25,743,179	7.56 (7.53–7.60)
2021	502,530	51,333,253	9.79 (9.76–9.82)	274,949	25,589,102	10.74 (10.70–10.78)	227,581	25,744,151	8.84 (8.80–8.88)
Mean	109,893	50,856,245	3.73 (3.71–3.74)	104,476	25,406,081	4.09 (4.07–4.11)	86,417	25,450,164	3.37 (3.35–3.39)

CI, confidence interval.